alvocidib
Showing 1 - 25 of 52
Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)
Completed
- Acute Myeloid Leukemia
- Alvocidib
- +2 more
-
Baltimore, Maryland
- +2 more
Apr 4, 2022
Acute Myeloid Leukemia Trial in Japan (Alvocidib, Cytarabine, Mitoxantrone)
Completed
- Acute Myeloid Leukemia
- Alvocidib
- +3 more
-
Yoshida-gun, Fukui, Japan
- +10 more
Apr 9, 2022
Acute Myeloid Leukemia (AML) Trial in Germany, United Kingdom, United States (Venetoclax, Alvocidib)
Completed
- Acute Myeloid Leukemia (AML)
- Venetoclax
- Alvocidib
-
Los Angeles, California
- +13 more
Jan 24, 2022
Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)
Terminated
- Acute Myeloid Leukemia
- Alvocidib
- +2 more
-
Scottsdale, Arizona
- +37 more
Apr 4, 2022
Lymphoma Trial in Canada (alvocidib)
Completed
- Lymphoma
- alvocidib
-
Halifax, Nova Scotia, Canada
- +3 more
Apr 7, 2020
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +16 more
- alvocidib
- +4 more
-
Baltimore, Maryland
- +1 more
Aug 3, 2018
Melanoma (Skin) Trial in Canada (alvocidib)
Completed
- Melanoma (Skin)
- alvocidib
-
Calgary, Alberta, Canada
- +49 more
Apr 7, 2020
Sarcoma Trial in Canada, United States (alvocidib)
Completed
- Sarcoma
- alvocidib
-
Duluth, Minnesota
- +60 more
Apr 7, 2020
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Minimally Differentiated
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +15 more
- alvocidib
- +3 more
-
Scottsdale, Arizona
- +10 more
Jul 3, 2017
B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- alvocidib
-
Columbus, OhioOhio State University Medical Center
Jun 2, 2017
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +2 more
- alvocidib
-
Columbus, OhioOhio State University Medical Center
Aug 31, 2016
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Terminated
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +27 more
- alvocidib
-
Columbus, OhioOhio State University Medical Center
Jun 27, 2016
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in
Completed
- Adult Acute Basophilic Leukemia
- +16 more
- alvocidib
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jul 14, 2015
Lymphoma, Prostate Cancer, Small Intestine Cancer Trial run by the NCI (alvocidib)
Completed
- Lymphoma
- +3 more
- alvocidib
-
Bethesda, MarylandMedicine Branch
Apr 28, 2015
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- alvocidib
- +6 more
-
Birmingham, Alabama
- +19 more
Jul 2, 2015
Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +8 more
- alvocidib
- +2 more
-
Duarte, California
- +4 more
May 9, 2014
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in New York (alvocidib, docetaxel)
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- alvocidib
- docetaxel
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
May 12, 2014
Solid Tumor Trial in Columbus (alvocidib, pharmacological study, laboratory biomarker analysis)
Terminated
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +2 more
-
Columbus, OhioOhio State University Medical Center
Feb 21, 2014
Solid Tumor Trial in New York (alvocidib, vorinostat, pharmacological study)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Feb 21, 2014
Solid Tumor Trial in New York (alvocidib, irinotecan HCl, cisplatin)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Feb 21, 2014
Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIIA Ovarian Epithelial Cancer Trial in
Completed
- Recurrent Ovarian Epithelial Cancer
- +9 more
- cisplatin
- +2 more
-
Rochester, MinnesotaMayo Clinic
May 6, 2014
Solid Tumor Trial in New York (alvocidib, fluorouracil, oxaliplatin)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 13, 2013
Hematopoietic/Lymphoid Cancer, Solid Tumor Trial in Boston (drug, other, radiation, procedure)
Terminated
- Hematopoietic/Lymphoid Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +4 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Dec 13, 2013
Solid Tumor Trial in Rochester (alvocidib, leucovorin calcium, fluorouracil)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +3 more
-
Rochester, MinnesotaMayo Clinic
Dec 10, 2013
Solid Tumor Trial in Boston, New York (gemcitabine HCl, alvocidib, pharmacological study)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- gemcitabine hydrochloride
- +2 more
-
Boston, Massachusetts
- +2 more
Jul 1, 2013